From the archive, originally posted by: [ mmm ]

US approves new Pfizer obesity drug for dogs

WASHINGTON, Jan 5 (Reuters) – U.S. health officials have approved the
first obesity drug aimed at treating Americans’ increasingly plump
pooches, the Food and Drug Administration said on Friday.

The drug, Pfizer Inc’.s (PFE.N: Quote, Profile , Research) Slentrol,
helps decrease appetite and fat absorption to help the roughly 5
percent of U.S. dogs that are obese lose weight, the FDA said. Another
20 percent to 30 percent are overweight, it added.

Also known as dirlotapide, the drug can also cause various side
effects, including vomiting, loose stools, diarrhea and lethargy.

“This is a welcome addition to animal therapies because dog obesity
appears to be increasing,” said Stephen Sundlof, head of FDA’s Center
for Veterinary Medicine.

Like their human counterparts, overweight dogs are also at risk for
developing diabetes, heart trouble, joint problems and other
complications, the FDA said.

At the same time, two-thirds of Americans are also overweight or
obese, government statistics show.

But Slentrol is not for human use and will carry warnings to
discourage people from using it, the FDA said.

The drug will only be available through veterinarians, the FDA said,
and will be given at various doses. Pfizer recommends use of Slentrol
for three months, according to the agency.

Representatives for Pfizer could not be immediately reached for
comment. Shares of Pfizer were up 2 cents at $26.40 in midday trade on
the New York Stock Exchange.